CLASS II Drug recall · Reported 5 Jun 2019 · FDA Enforcement Report
Bevacizumab 5 mg recalled by Avella of Deer Valley, Inc.
Avella of Deer Valley, Inc. Store 38 is recalling Bevacizumab 5 mg, distributed nationwide in the US. The recall was initiated on 3 May 2019 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-1308-2019
- FDA event ID
- 82790
- Recalling firm
- Avella of Deer Valley, Inc. Store 38, Phoenix, AZ
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 3 May 2019
- FDA classified
- 29 May 2019
- Reported
- 5 Jun 2019
- Type
- Voluntary: Firm initiated
- Customers notified by
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
- Reason category
- Sterility
- Drug class
- Injectable & IV Drugs
Timeline
| 3 May 2019 | Recall initiated by company | |
| 29 May 2019 | Classified by FDA | +26 days |
| 5 Jun 2019 | Published in enforcement report | +7 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Lack of assurance of sterility
A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.
Product as listed by the FDA
Bevacizumab 2.5 mg/0.1 mL, packaged in a Prefilled Syringe, Rx only, AVELLA SPECIALTY PHARMACY 24416 N. 19TH AVENUE PHOENIX, AZ 85085, NDC 42852-001-27
Where it was distributed
U.S.A. nationwide
Questions about this recall
Is Bevacizumab 5 mg recalled?
Yes. Avella of Deer Valley, Inc. Store 38 recalled Bevacizumab 5 mg on 3 May 2019. The recall is Class II and its status is Terminated. Recall number D-1308-2019.
Why was it recalled?
Lack of assurance of sterility
Which lots are affected?
Lot #: 138-20191202@64, Exp 05/13/19
Where was it sold?
U.S.A. nationwide
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Avella of Deer Valley, Inc. Store 38
All 50| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Povidone Iodine, 5% Ophthalmic Solution per droptainer recalled | Avella of Deer Valley, Inc. Store 38 | Sterility | Nationwide |
| Drug | CLASS II | MAGnesium 2gm sulfate, added to D5W, Volume recalled | Avella of Deer Valley, Inc. Store 38 | Sterility | 13 states |
| Drug | CLASS II | MAGnesium 1gm sulfate, added to D5W, Volume recalled | Avella of Deer Valley, Inc. Store 38 | Sterility | 13 states |
| Drug | CLASS II | Labetalol 20mg, HCL, USP Injectable Solution, 20mg recalled | Avella of Deer Valley, Inc. Store 38 | Packaging Defects | 13 states |
| Drug | CLASS II | MAGnesium 2 gm sulfate, added to NS, Sterile single use recalled | Avella of Deer Valley, Inc. Store 38 | Sterility | 13 states |